NCT04177329

Brief Summary

Patients with subarachnoid haemorrhage frequently develop cardiac complications affecting their outcome

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2019

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 23, 2019

Completed
2 months until next milestone

First Posted

Study publicly available on registry

November 26, 2019

Completed
5 days until next milestone

Study Start

First participant enrolled

December 1, 2019

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2020

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2020

Completed
Last Updated

November 26, 2019

Status Verified

November 1, 2019

Enrollment Period

6 months

First QC Date

September 23, 2019

Last Update Submit

November 23, 2019

Conditions

Subarachnoid Hemorrhage

Outcome Measures

Primary Outcomes (2)

  • Electrocadriogram

    to measure heart rate (beats/minute) in subarachnoid hemorrhage patients

    1 miute

  • Echocardiogarphy

    to measure ejection fraction (%) in subarachnoid hemorrhage patients

    30 minute

Secondary Outcomes (1)

  • serum treponin level

    30 minute

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients presented with spontaneous subarachnoid hemorrhage admitted to our department included in this study

You may qualify if:

  • Patients diagnosed as spontaneous subarachnoid hemorrhage.
  • SSAH patients aged (18-70 years) of both sexes

You may not qualify if:

  • History or current evidence of any CNS disease other than SAH which may cause cardiac complications.
  • History or current evidence of medical illness as endocrinal and metabolic disorders which may cause cardiac complications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Subarachnoid Hemorrhage

Condition Hierarchy (Ancestors)

Intracranial HemorrhagesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
princible investegator Resident doctor at neuro psychiatry department

Study Record Dates

First Submitted

September 23, 2019

First Posted

November 26, 2019

Study Start

December 1, 2019

Primary Completion

May 31, 2020

Study Completion

December 1, 2020

Last Updated

November 26, 2019

Record last verified: 2019-11